CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 540 enrolled
Drug / intervention
Hamamatsu NanoZoomer S360MD Digital Slide Scanner Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03992768
NCT03992768N/ACompleted
CompareCT.gov

Clinical Validation for Feature Detection Precision by WSI Using Hamamatsu NanoZoomer S360MD Digital Slide Scanner System

Hamamatsu Photonics K.K.·interventional·Posted Jun 20, 2019·Updated Dec 22, 2022

In Brief

A clinical study evaluating Hamamatsu NanoZoomer S360MD Digital Slide Scanner System for Pathology. Completed, enrolled 540 participants across 3 sites.

Detailed Summary

The objective of this study is to evaluate the repeatability and reproducibility of detection of histological features using whole slide imaging

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPathology
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 20, 2019
Enrollment StartJun 12, 2019
Primary CompletionSep 30, 2021
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 7.0 years ago

Interventions

Hamamatsu NanoZoomer S360MD Digital Slide Scanner Systemdevice

Detection of pathology features using whole slide imaging